Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of NanoPac Focal Therapy for Prostate Cancer in Subjects Undergoing Radical Prostatectomy

NCT04221828 is registered in ClinicalTrials.gov with NanOlogy, LLC as lead sponsor.

NCT NCT04221828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04221828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of NanoPac Focal Therapy for Prostate Cancer in Subjects Undergoing Radical Prostatectomy
Lead sponsor
NanOlogy, LLC
Phase
Phase 2
Overall status
Terminated
Start date
October 20, 2020
Completion date
February 8, 2021
Enrollment
1 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

genital neoplasms, male, localized cancer, prostate adenocarcinoma, prostate cancer, prostate cancer adenocarcinoma, prostatic neoplasm, urogenital neoplasms